OptimizeRx Corporation Announces CEO Transition and Interim Appointment
OptimizeRx Corporation, listed on the Nasdaq under the symbol OPRX, recently disclosed in an 8-K filing to the Securities and Exchange Commission that their Chief Executive Officer (CEO) and Board Member, William J. Febbo, will be stepping down from his roles, effective December 31, 2024. This move is to enable him to pursue other opportunities. […]
More Stories
D.R. Horton (DHI) – Investment Analysts’ Recent Ratings Updates
A number of firms have modified their ratings and price targets on shares of D.R. Horton (NYSE: DHI) recently: 12/17/2024...
Top 10 Motivational Movies for Students to Supercharge Them
As we grow up, every individual faces those moments when our inner spark feels dim and needs a little igniting....
VictoryShares Free Cash Flow ETF (NASDAQ:VFLO) Short Interest Update
VictoryShares Free Cash Flow ETF (NASDAQ:VFLO – Get Free Report) saw a large increase in short interest in the month...
H-CYTE (OTCMKTS:HCYTD) Shares Down 49.5% – What’s Next?
H-CYTE, Inc. (OTCMKTS:HCYTD – Get Free Report) fell 49.5% on Wednesday . The stock traded as low as $2.02 and...
Sonendo (NYSE:SONX) Shares Down 15.9% – Should You Sell?
Sonendo, Inc. (NYSE:SONX – Get Free Report)’s stock price traded down 15.9% during mid-day trading on Wednesday . The stock...
NextGen Acquisition Corp. II (OTCMKTS:NGCAU) Trading Down 5.4% – Here’s Why
NextGen Acquisition Corp. II (OTCMKTS:NGCAU – Get Free Report)’s stock price fell 5.4% during trading on Wednesday . The stock...